随着诊断技术的提高,新发现患者日趋增多,肺动脉高压治疗药物层出不穷,其市场蕴藏巨大潜力,众多制药巨头已进军这一市场,而国内市场仍是一片空白,开发空间巨大。 With the improvement of diagnostic techniques, the newly discovered patients are getting more and more. The treatment of pulmonary hypertension drugs emerges in an endless stream. There is great potential in the market. Many pharmaceutical giants have already entered this market. However, the domestic market is still blank and the space for development is huge.